2300 participants
Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-03
- Start Date:
- 2026-12-31
- Completion:
- 2030-10-31
Conditions
- Systemic Lupus Erythematosus
- Sjögren's Disease
- Psoriasis
- Psoriatic Arthritis
Interventions
- DRUG
No Results Yet